tiprankstipranks
Intra-Cellular Therapies (ITCI)
NASDAQ:ITCI

Intra-Cellular Therapies (ITCI) Income Statement

792 Followers

Intra-Cellular Therapies Income Statement

Last quarter (Q3 2023), Intra-Cellular Therapies's total revenue was $126.17M, an increase of 75.56% from the same quarter last year. In Q3, Intra-Cellular Therapies's net income was $-6.00M. See Intra-Cellular Therapies’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 419.48M$ 250.31M$ 83.80M$ 22.53M$ 0.00$ 0.00
Cost of Revenue
---$ 1.90M$ 0.00$ 0.00
Gross Profit
$ 420.14M$ 250.31M$ 83.80M$ 20.64M$ 0.00$ 0.00
Operating Expense
$ 592.84M$ 513.94M$ 369.49M$ 251.86M$ 154.01M$ 162.27M
Operating Income
$ -158.37M$ -263.63M$ -285.69M$ -231.23M$ -154.01M$ -162.27M
Net Non Operating Interest Income Expense
$ 17.76M$ 7.38M$ 1.57M$ 4.24M$ 6.29M$ 7.14M
Other Income Expense
------
Pretax Income
$ -154.93M$ -256.25M$ -284.12M$ -226.99M$ -147.72M$ -155.13M
Tax Provision
$ 188.00K$ 6.00K$ 6.00K$ 13.51K$ 1.60K$ 1.60K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -136.86M$ -215.37M$ -284.13M$ -227.01M$ -147.72M$ -155.13M
Basic EPS
$ -2.39$ -2.72$ -3.50$ -3.23$ -2.68$ -2.84
Diluted EPS
$ -1.61$ -2.72$ -3.50$ -3.23$ -2.68$ -2.84
Basic Average Shares
$ 381.27M$ 94.05M$ 81.25M$ 70.36M$ 55.19M$ 54.71M
Diluted Average Shares
$ 381.27M$ 94.05M$ 81.25M$ 70.36M$ 55.19M$ 54.71M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 592.84M$ 513.94M$ 369.49M$ 253.76M$ 154.01M$ 162.27M
Net Income From Continuing And Discontinued Operation
$ -155.12M$ -256.26M$ -284.13M$ -227.01M$ -147.72M$ -155.13M
Normalized Income
$ -52.82M$ -202.44M-$ -227.01M$ -147.72M$ -155.13M
Interest Expense
-----$ 0.00
EBIT
$ -158.32M$ -256.25M$ -284.12M$ -231.23M$ -154.01M$ -162.27M
EBITDA
$ -162.48M$ -255.15M$ -287.67M$ -230.70M$ -153.53M$ -161.90M
Currency in USD

Intra-Cellular Therapies Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis